Inhatarget Therapeutics
Actief
0732.994.752 - 6041 Charleroi
People administring Inhatarget Therapeutics
Name | Role / Mandate | Year |
---|---|---|
Arthur De Boeck | Vertegenwoordiger | 2021 |
Caroline Baudier | Vertegenwoordiger | 2021 |
Eric Leire | Vertegenwoordiger | 2021 |
Frédéric De Coninck | Vertegenwoordiger | 2021 |
Héléna Pozios | Vertegenwoordiger | 2021 |
Karim Amighi | Bestuurder | 2021 |
Marie Bouillez | Vertegenwoordiger | 2021 |
Mohamed Lotfi Yelles Chaouche | Vertegenwoordiger | 2021 |
Mohamed Sebti | Bestuurder | 2021 |
Rémi Rosière | Bestuurder | 2021 |
Companies administring Inhatarget Therapeutics
Name | Enterprise # | Role | Year |
---|---|---|---|
EEBIC VENTURES | 0507.740.263 | Bestuurder | 2021 |
FDC CONSULT | 0677.522.432 | Bestuurder | 2021 |
GALEPHAR PHARMACEUTICAL RESEARCH | Bestuurder | 2021 | |
GENFLOW BIOSCIENCES | Bestuurder | 2021 | |
S.M.B. TECHNOLOGY | 0431.842.812 | Bestuurder | 2021 |
SAMBRINVEST & FREMOLUC HOLDING | 0738.583.536 | Bestuurder | 2021 |
THEODORUS IV | 0707.902.931 | Bestuurder | 2021 |
Companies that are administered by Inhatarget Therapeutics
Name | Enterprise # | Role | Year |
---|---|---|---|
No data available |
Companies holding participations in Inhatarget Therapeutics
Participations in | Value | Amount | % Direct | % Indirect | Type |
---|---|---|---|---|---|
Sambrinvest & Fremoluc Holding | Sambrinvest & Fremoluc Holding | 0738.583.536 | Shareholder | ||
6K venture capital | 6K venture capital | 0809.505.580 | Shareholder | ||
THEODORUS IV | THEODORUS IV | 0707.902.931 | Shareholder |
Inhatarget Therapeutics has participations in
Participations in | Value | Amount | % Direct | % Indirect | Type |
---|---|---|---|
No data available |